Cleared Special

COMPASS VASCULAR ACCESS / ACCESS PORT / LUMBAR PUNCTURE / INTRACRANIAL PRESSURE (K103715) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
30d
Days
Class 2
Risk

K103715 is an FDA 510(k) clearance for the COMPASS VASCULAR ACCESS / ACCESS PORT / LUMBAR PUNCTURE / INTRACRANIAL PRESSURE. Classified as Transducer, Blood-pressure, Extravascular (product code DRS), Class II - Special Controls.

Submitted by Mirador Biomedical, Inc. (Seattle, US). The FDA issued a Cleared decision on January 20, 2011 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2850 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Mirador Biomedical, Inc. devices

Submission Details

510(k) Number K103715 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2010
Decision Date January 20, 2011
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DRS Transducer, Blood-pressure, Extravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRS Transducer, Blood-pressure, Extravascular

All 147
Devices cleared under the same product code (DRS) and FDA review panel - the closest regulatory comparables to K103715.
FloTrac sensors
K242909 · Edwards Lifesciences, LLC · Mar 2025
Meritrans ECO Reusable Pressure Transducer, Meritrans ECO Domes
K221782 · Merit Medical Pte. , Ltd. · Mar 2023
SERIES 51 AND 53 DISPOSABLE PRESSURE TRANSDUCERS
K904777 · Baxter Healthcare Corp · Jan 1991
MINIFLOW DISPOSABLE PRESSURE TRANSDUCER 63-600F
K885296 · Baxter Healthcare Corp · Jan 1989
USCI ELECTRONIC MANOMETER
K830093 · C.R. Bard, Inc. · Jan 1983
BARD CARDIOPULMONARY MONITORING LINES
K820186 · C.R. Bard, Inc. · Feb 1982